<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00219869</url>
  </required_header>
  <id_info>
    <org_study_id>GAL-EMR-4006</org_study_id>
    <nct_id>NCT00219869</nct_id>
  </id_info>
  <brief_title>Galantamine in the Treatment of Post-Traumatic Headache</brief_title>
  <official_title>Galantamine in the Preventive Treatment of Chronic Post-Traumatic Headache</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rapoport, Alan, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ortho-McNeil Neurologics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Rapoport, Alan, M.D.</source>
  <brief_summary>
    <textblock>
      Most patients with CPTH present with additional major cognitive, behavioral and somatic
      problems. Most drugs used currently have a negative influence on cognition. Therefore,
      treatment strategies addressing both the headache and cognitive disturbances in patients with
      CPTH are necessary. (CPTH; Chronic Post Traumatic Headache).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Headache is the most common symptom after a closed head injury, persisting for more then 2
      months in 60% of the patients. CPTH is an important cause of consultations in neurology
      offices and headache clinics, posing a severe burden and affecting the quality of life of
      sufferers.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2005</start_date>
  <completion_date>August 2005</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Headache Efficacy Measure; number of pain free days after 3 months</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Consumption of rescue medication</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days with moderate or severe headache after 3 months.</measure>
  </secondary_outcome>
  <enrollment>30</enrollment>
  <condition>Post-Traumatic Headache</condition>
  <condition>Head Trauma,Closed</condition>
  <condition>Retention Disorders,Cognitive</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Galantamine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age range 18-75 CPTH according to ICHD-2 Fertile woman using adequate birth control Willing
        and able to give informed consent Willing and able to complete the entire course of the
        study to comply with study instructions Stable does of preventive medication

        Exclusion Criteria:

        Subject is pregnant or lactating Significant medical or psychiatric disease Previous
        failure to 4 or more adequate trials of preventive medication Patient on non-stable dose of
        medication used to prevent CPTH
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Rapoport, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The New England Center for Headache</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lori L Flanagan, RN</last_name>
    <phone>203-322-2748</phone>
    <email>lc@nech.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kathy Diomede, RN</last_name>
    <phone>203-322-2748</phone>
    <email>kd@nech.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The New England Center for Headache</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Flanagan, RN</last_name>
      <phone>203-322-2748</phone>
      <email>lc@nech.net</email>
    </contact>
    <contact_backup>
      <last_name>Kathy Diomede</last_name>
      <phone>203-322-2748</phone>
      <email>kd@nech.net</email>
    </contact_backup>
    <investigator>
      <last_name>Alan Rapoport, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stewart Tepper, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fred Sheftell, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcelo Bigal, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.headachenech.com</url>
    <description>The New England Center for Headache page</description>
  </link>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>September 13, 2005</last_update_submitted>
  <last_update_submitted_qc>September 13, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2005</last_update_posted>
  <keyword>Post</keyword>
  <keyword>Traumatic</keyword>
  <keyword>Headache</keyword>
  <keyword>Cognitive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Craniocerebral Trauma</mesh_term>
    <mesh_term>Post-Traumatic Headache</mesh_term>
    <mesh_term>Memory Disorders</mesh_term>
    <mesh_term>Head Injuries, Closed</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Galantamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

